Patient#	Sample#	GDP:(GTP, active),(RAC1/GDP, active),(RhoA/GDP, active),	AKT1-2:(AKT1-2, protein),	CTNNA1:(CTNNA1, protein),	CTNND1:(CTNND1, protein),	EGFR:(EGFR, protein),	SRC:(SRC, protein),	AKT1-2-active	apoptosis:(AKT1-2-active, active),	CASR	E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin	EGFR(dimer):(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(EGFR, active),	JUB:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(JUB, protein),	PI3K:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),	PIP5K1A:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(PIP5K1A, protein),	VASP:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(VASP, protein),	ZYX:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(ZYX, protein),	formin 1:(E-cadherin/Ca2+/beta catenin-gamma catenin/alpha catenin/p120 catenin, active),(formin 1, protein),	PAK1:(EGFR(dimer), active),(GTP, active),(RAC1/GDP, active),	PI-4-5-P2:(PI-4-P, active),(PIP5K1A, active),	actin cable formation:(VASP, active),(formin 1, active),	adherens junction organization:(JUB, active),(VASP, active),(formin 1, active),	establishment of polarity of embryonic epithelium:(VASP, active),	DAG:(PI-4-5-P2, active),	PI-3-4-5-P3:(PI-4-5-P2, active),(PI3K, active),	PLCG1:(PI-3-4-5-P3, active),(PLCG1, protein),	IP3:(PI-4-5-P2, active),(PLCG1, active),	Ca2+:(IP3, active),	RhoA/GTP:(Ca2+, active),(GTP, active),(RhoA/GDP, active),	keratinocyte differentiation:(AKT1-2-active, active),(Ca2+, active),	FYN:(CASR, active),(FYN, protein),(RhoA/GTP, active),	E-cadherin/beta catenin-gamma catenin/alpha catenin/p120 catenin:(CTNNA1, active),(CTNND1, active),(E-cadherin/beta catenin-gamma catenin, active),(FYN, active),(SRC, active),	
